북미의 피부 필러 시장 예측(-2031년) : 지역별 분석 - 제품별, 재료별, 용도별, 최종사용자별

The North America dermal fillers market was valued at US$ 1,613.09 million in 2023 and is expected to reach US$ 2,874.29 million by 2031; it is estimated to register a CAGR of 7.5% from 2023 to 2031.

Increasing Preference for Minimally Invasive Procedures Fuels North America Dermal Fillers Market

Minimally invasive procedures have gained popularity among consumers, as they offer several advantages over traditional surgical methods. These procedures involve less risk, minimal scarring, shorter recovery times, and often require only local anesthesia. Additionally, advancements in cosmetic techniques have made dermal fillers more effective and safer than ever before. Newer formulations of fillers are longer-lasting and provide more natural-looking results. This has increased consumer confidence in these procedures and contributed to their growing popularity. According to the statistics from the Aesthetic Society, 649,176 filler procedures were performed in the US in 2022, and dermal filler procedures accounted for 14% of the total nonsurgical revenue in the US in 2022. This makes it the third most common nonsurgical aesthetic procedure in 2022. Similarly, according to the Global Survey 2022 report by the International Society of Aesthetic Plastic Surgery (ISAPS), the total number of nonsurgical and surgical aesthetic procedures increased by 11.2% in 2022 compared to 2021, with more than 14.9 million surgical and 18.8 million nonsurgical procedures performed worldwide.

Furthermore, age plays a substantial role in determining the unique needs of medical aesthetic procedures; adults are more inclined toward minimally invasive approaches. Furthermore, people aged 35-55 have a preference for minimally invasive cosmetic procedures over surgery. Plastic surgeons are increasingly interested in exploring them, and minimally invasive cosmetic and aesthetic procedures are now considered interdisciplinary. The advancement of nonsurgical technologies and new treatment alternatives has made aesthetics more accessible to a wider population. Patients in their 20s and 30s are driving this trend.

Overall, the benefits and accuracy offered by minimally invasive procedures over traditional surgery are expected to continue to drive the market growth during the forecast period. The ever-increasing interest in retaining a youthful appearance has facilitated various minimally invasive dermatological techniques. The field of cosmetic dermatology has been expanding globally. With the ever-increasing popularity of nonsurgical enhancement and an increasing number of patients who have been treated, the demand for fillers continues to rise, boosting the North America dermal fillers market growth.

North America Dermal Fillers Market Overview

North America dermal fillers market is expected to witness substantial growth owing to the increasing focus of market players in the US and Canada, high per capita spending, and the presence of renowned beauty brands in the region. The changing and busy lifestyles of consumers in the region have led to a rise in the demand for multifunctional cosmetics and personal care formulations. In addition, the obesity risk and implications caused by cellulite accumulation have attracted consumers toward special cosmetic and beauty procedures. Moreover, the region has a huge population base willing to get wrinkle-free and acne-free skin, backed up by the launch of new beauty procedures.

North America Dermal Fillers Market Revenue and Forecast to 2031 (US$ Million)

North America Dermal Fillers Market Segmentation

The North America Dermal Fillers Market is categorized into product, material, application, end user, and country.

Based on product, the North America Dermal Fillers Market is bifurcated biodegradable and nonbiodegradable. The biodegradable segment held a larger market share in 2023.

In terms of material, the North America Dermal Fillers Market is categorized calcium hydroxylapatite, hyaluronic acid, collagen, poly-l-lactic acid, polmethylmethacrylate (PMMA), fat fillers, and others. The hyaluronic acid segment held the largest market share in 2023.

By application, the North America Dermal Fillers Market is segmented into facial line correction treatment, lip enhancement, face lift, scar treatment, and others. The lip enhancement segment held a larger market share in 2023.

By end user, the North America Dermal Fillers Market is segmented into multispecialty hospitals, dermatology clinics, ambulatory surgical centers, and others. The dermatology clinics segment held a larger market share in 2023.

By country, the North America Dermal Fillers Market is segmented into the US, Canada, and Mexico. The US dominated the North America Dermal Fillers Market share in 2023.

AbbVie Inc, Galderma SA, Merz Pharma GmbH & Co KGaA, Suneva Medical, TEOXANE LABORATORIES, Prollenium Medical Technologies, and Sinclair Pharma Ltd are some of the leading companies operating in the North America Dermal Fillers Market.

Table Of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. North America Dermal Fillers Market - Key Market Dynamics

• 4.1 Market Drivers
  • 4.1.1 Increasing Preference for Minimally Invasive Procedures
  • 4.1.2 Rising Attraction of Consumers Toward Beauty and Wellness
• 4.2 Market Restraints
  • 4.2.1 High Cost of Dermal Filler Procedures
• 4.3 Market Opportunities
  • 4.3.1 Growing Medical Tourism for Cosmetic Procedures
• 4.4 Future Trends
  • 4.4.1 Growing Adoption of Combination Therapies
• 4.5 Impact of Drivers and Restraints:

5. Dermal Fillers Market - North America Market Analysis

• 5.1 North America Dermal Fillers Market Revenue (US$ Million), 2021-2031
• 5.2 North America Dermal Fillers Market Forecast Analysis

6. North America Dermal Fillers Market Analysis - by Product

• 6.1 Biodegradable
  • 6.1.1 Overview
  • 6.1.2 Biodegradable: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
• 6.2 Non-biodegradable
  • 6.2.1 Overview
  • 6.2.2 Non-biodegradable: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)

7. North America Dermal Fillers Market Analysis - by Material

• 7.1 Calcium Hydroxylapatite
  • 7.1.1 Overview
  • 7.1.2 Calcium Hydroxylapatite: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
• 7.2 Hyaluronic Acid
  • 7.2.1 Overview
  • 7.2.2 Hyaluronic Acid: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
• 7.3 Collagen
  • 7.3.1 Overview
  • 7.3.2 Collagen: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
• 7.4 Poly-L-Lactic Acid
  • 7.4.1 Overview
  • 7.4.2 Poly-L-Lactic Acid: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
• 7.5 Polmethylmethacrylate (PMMA)
  • 7.5.1 Overview
  • 7.5.2 Polmethylmethacrylate (PMMA): North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
• 7.6 Fat Fillers
  • 7.6.1 Overview
  • 7.6.2 Fat Fillers: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
• 7.7 Others
  • 7.7.1 Overview
  • 7.7.2 Others: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)

8. North America Dermal Fillers Market Analysis - by Application

• 8.1 Facial Line Correction Treatment
  • 8.1.1 Overview
  • 8.1.2 Facial Line Correction Treatment: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
• 8.2 Lip Enhancement
  • 8.2.1 Overview
  • 8.2.2 Lip Enhancement: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
• 8.3 Face Lift
  • 8.3.1 Overview
  • 8.3.2 Face Lift: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
• 8.4 Scar Treatment
  • 8.4.1 Overview
  • 8.4.2 Scar Treatment: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
• 8.5 Others
  • 8.5.1 Overview
  • 8.5.2 Others: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)

9. North America Dermal Fillers Market Analysis - by End User

• 9.1 Multispecialty Hospitals
  • 9.1.1 Overview
  • 9.1.2 Multispecialty Hospitals: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
• 9.2 Dermatology Clinics
  • 9.2.1 Overview
  • 9.2.2 Dermatology Clinics: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
• 9.3 Ambulatory Surgical Centers
  • 9.3.1 Overview
  • 9.3.2 Ambulatory Surgical Centers: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
• 9.4 Others
  • 9.4.1 Overview
  • 9.4.2 Others: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)

10. North America Dermal Fillers Market - Country Analysis

• 10.1 North America Dermal Fillers Market - Revenue and Forecast Analysis - by Country
  • 10.1.1 North America Dermal Fillers Market - Revenue and Forecast Analysis - by Country
  • 10.1.2 US Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.1.2.1 US Dermal Fillers Market Breakdown, by Product
    • 10.1.2.2 US Dermal Fillers Market Breakdown, by Material
    • 10.1.2.3 US Dermal Fillers Market Breakdown, by Application
    • 10.1.2.4 US Dermal Fillers Market Breakdown, by End User
  • 10.1.3 Canada Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.1.3.1 Canada Dermal Fillers Market Breakdown, by Product
    • 10.1.3.2 Canada Dermal Fillers Market Breakdown, by Material
    • 10.1.3.3 Canada Dermal Fillers Market Breakdown, by Application
    • 10.1.3.4 Canada Dermal Fillers Market Breakdown, by End User
  • 10.1.4 Mexico Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.1.4.1 Mexico Dermal Fillers Market Breakdown, by Product
    • 10.1.4.2 Mexico Dermal Fillers Market Breakdown, by Material
    • 10.1.4.3 Mexico Dermal Fillers Market Breakdown, by Application
    • 10.1.4.4 Mexico Dermal Fillers Market Breakdown, by End User

11. Dermal Fillers Market - Industry Landscape

• 11.1 Overview
• 11.2 Growth Strategies in Dermal Fillers Market
• 11.3 Organic Growth Strategies
  • 11.3.1 Overview
• 11.4 Inorganic Growth Strategies
  • 11.4.1 Overview

12. Dermal Fillers Market - Competitive Landscape

• 12.1 Heat Map Analysis by Key Players
• 12.2 Company Positioning and Concentration - Company Share Analysis - 2022
• 12.3 Company Product Revenue

13. Company Profiles

• 13.1 AbbVie Inc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
• 13.2 Galderma SA
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
• 13.3 Merz Pharma GmbH & Co KGaA
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
• 13.4 Suneva Medical
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
• 13.5 TEOXANE LABORATORIES
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
• 13.6 Prollenium Medical Technologies
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
• 13.7 Sinclair Pharma Ltd
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments

14. Appendix

• 14.1 About The Insight Partners